Last updated 2026-07-19
- Acquired by Chengdu Kanghong Pharmaceutical Group for $56M, Sep 2018
Total raised
—
Last: Undisclosed Round 2015-11
Stage
Acquired
Founded
2005
Headcount
18
HQ
Caesarea, Israel
Sector
Health Tech & Life Sciences
About
IOPtima is a rapidly growing company focused on developing minimally invasive and innovative surgical ophthalmic devices. Its flagship product, the IOPtimate, is a surgical system for the treatment of glaucoma that utilizes CO2 laser technology to significantly reduce internal eye pressure without penetrating the eye. The company also offers a line of patented eye drops to treat ocular surface diseases. IOPtima is a Kanghong Pharmaceutical company.
Headcount over time
18 employees (2026-09) · 1 point
Offices
Caesarea, Israel · HQ / main office
Q&A
- What is IOPtima's primary focus?
- IOPtima focuses on developing minimally invasive and innovative surgical ophthalmic devices, including its flagship product, the IOPtimate, for glaucoma treatment.
- When was IOPtima founded?
- IOPtima was founded in January 2005.
- What is IOPtima's current status?
- IOPtima was acquired by Chengdu Kanghong Pharmaceutical Group in September 2018.
- What is the primary product offered by IOPtima?
- IOPtima's flagship product is the IOPtimate, a surgical system that uses CO2 laser technology to treat glaucoma by reducing internal eye pressure without penetration.
- How much funding has IOPtima raised in total?
- IOPtima has raised a total of $7.2 million.
- When was IOPtima's last funding round and who were the investors?
- IOPtima's last funding round was in November 2015, with investments from Infinity China and Diamond Bio Fund.
- What is IOPtima's employee count?
- IOPtima has an employee count in the 1-10 range.
- Does IOPtima hold any patents?
- Yes, IOPtima holds one patent.
Team · 6
Ronen Castro
Founder · CEO
Amnon Nahum-Sharon
Founder · COO
Shay Leventhal-Gabay
VP QA & RA
Eran Kaplan
CEO
Amelie Saraby
Business Dev. and Marketing Director
Yaron Sfadyah
Director of Business Development
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
SensingLaser
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
medical-deviceseye-diseasesminimally-invasivesurgerylasersglaucomaophthalmologyhospitalspharma-companiesclinicshealthcare-providersmedical-technologiesoptronics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | ioptima.com |
|---|---|
| linkedin.com/company/5022298 | |
| YouTube | youtube.com/user/IOPtimaVideos |
Identifiers & details
| Founded | 2005-1 |
|---|---|
| Employees (exact) | 18 |
| Status reason | Acquired by Chengdu Kanghong Pharmaceutical Group on Sep, 2018 |
Acquisitions & public offerings
Acquired by Chengdu Kanghong Pharmaceutical Group 2018-09 $56.0M
Radar intelligence
Patents
| EPO | 4 |
|---|
Web history (Wayback)
| Domain | ioptima.com |
|---|
Certificate / subdomain footprint
| Subdomains | 4 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513264424 |
|---|---|
| Status | בפרוק ע~י בימ~ש — CLOSED |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2002-07-15 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 2 — charge (1), dissolution (1) |
| Closure date | 2026-04-27 |
| Registered address | ידיד החולות 3 קיסריה |
Recent registry events
| Date | Event |
|---|---|
| 2025-11-30 | סילוק שעבוד |
| 2026-04-27 | פירוק ע~י בית משפט (חדלות פירעון) |